Anti-infective Efficacy of a 3D Printed PLGA/HA Scaffold Grafted with Quaternised Chitosan
Yang Ying,Yang Shengbing,Ao Haiyong,Tang Tingting
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.01201
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Anti-infective efficacy of a 3D printed PLGA/HA scaffold grafted with quaternised chitosan Ying Yang1*, Shengbing Yang1*, Haiyong Ao1* and Tingting Tang1 1 Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, China Contaminated or infectious bone defect remains a serious complicated challenge in current orthopedic surgery and the bone substitute with both osteoconductivity and anti-bacterial potential represents an ideal treatment strategy. In previous study, we have developed a novel quaternised chitosan (hydroxypropyltrimethyl ammonium chloride chitosan, HACC) and demonstrated that it exhibited strong antibacterial activity[1],[2]. In this study, the HACC was grafted to the 3D printed bioactive porous scaffolds, which made of polylactide-co-glycolide (PLGA) or impregnated with hydroxyapatite (HA) (weight ratio, PLGA:HA=9:1). Three standard strains, Staphylococcus aureus (ATCC25923), Staphylococcus epidermidis (ATCC35984) and methicillin-resistant Staphylococcus aureus (ATCC43300), and one clinical isolates, methicillin-resistant S.epidermidis (MRSE287), were selected to evaluate the bacterial adhesion and biofilm formation on the materials at 4, 24 and 48h using the spread plate method, tissue culture plate (TCP) method and confocal laser scanning microscopy (CLSM) in vitro. We found that both PLGA/HA/HACC and PLGA/HACC composites could significantly inhibit bacterial adhesion and biofilm formation compared with PLGA or PLGA/HA. Meanwhile, human bone marrow derived mesenchymal stem cells were used to assess the osteoactivity of the scaffold and we found that HA impregnated scaffolds including PLGA/HA and PLGA/HA/HACC exhibited significantly better cell attachment, proliferation, spreading and osteogenic differentiation compared with the PLGA or PLGA/HACC. Furthermore, the scaffold contaminated with a bioluminescent S.aureus strain (ATCC12600, Xen29) was implanted subcutaneously in SD rats. The real-time monitoring of the IVIS Imaging System showed more evident decrease in bacterial counts in the scaffolds of PLGA/ HA /HACC and PLGA/HACC compared with the other two scaffolds without HACC grafting. Taken all together, our findings may develop a good foundation for potential clinical validation of this inovative bioactive porous scaffold for combating infectious bone defect. NSFC-DG-RTD Joint Scheme (Project No. 51361130034); the European Union’s 7th Framework Program under grant agreement n° NMP3-SL-2013-604517References:[1] Peng ZX, et al. Carbohydrate Polymers 2010, 81（2）：275-2834.[2] Tan HL, et al. Biomaterials 2012; 33:365-377. Keywords: Bacteria, Infection, 3D scaffold, Bone repair Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: New Frontier Oral Topic: Anti-infective biomaterials Citation: Yang Y, Yang S, Ao H and Tang T (2016). Anti-infective efficacy of a 3D printed PLGA/HA scaffold grafted with quaternised chitosan. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01201 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. * Correspondence: Dr. Ying Yang, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai, China, Email1 Dr. Shengbing Yang, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai, China, Email2 Dr. Haiyong Ao, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedic Surgery, Shanghai, China, Email3 Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Ying Yang Shengbing Yang Haiyong Ao Tingting Tang Google Ying Yang Shengbing Yang Haiyong Ao Tingting Tang Google Scholar Ying Yang Shengbing Yang Haiyong Ao Tingting Tang PubMed Ying Yang Shengbing Yang Haiyong Ao Tingting Tang Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.